Brief: Medipal Holdings Announces European Commission Granted Orphan Drug Designation To JR-446
24/06/2025 20:40
June 24 (Reuters) - JCR Pharmaceuticals Co Ltd 4552.T: MEDIPAL HOLDINGS : ANNOUNCED EUROPEAN COMMISSION GRANTED ORPHAN DRUG DESIGNATION TO JR-446 Source text: ID:nBw4RVq6Ha Further company coverage: 4552.T ((Reuters.Briefs@thomsonreuters.com;))